Combined Usage of Trimetazidine With 3-Bromopyruvate May Lead to Cardiotoxicity by Activating Oxidative Stress and Apoptosis in Rats
In conclusion, 3-BrPA and TMZ are not recommended for concurrent use.
Source: Journal of Cardiovascular Pharmacology - Category: Cardiology Tags: Original Article Source Type: research
More News: Antidoxidants | Cardiology | Cardiovascular | Drugs & Pharmacology | Heart | Heart Failure | Study